» Articles » PMID: 39202661

Evaluating the Role of Susceptibility Inducing Cofactors and of Acetaminophen in the Etiology of Autism Spectrum Disorder

Overview
Journal Life (Basel)
Specialty Biology
Date 2024 Aug 29
PMID 39202661
Authors
Affiliations
Soon will be listed here.
Abstract

More than 20 previously reported lines of independent evidence from clinical observations, studies in laboratory animal models, pharmacokinetic considerations, and numerous temporal and spatial associations indicate that numerous genetic and environmental factors leading to inflammation and oxidative stress confer vulnerability to the aberrant metabolism of acetaminophen during early development, leading to autism spectrum disorder (ASD). Contrary to this conclusion, multivariate analyses of cohort data adjusting for inflammation-associated factors have tended to show little to no risk of acetaminophen use for neurodevelopment. To resolve this discrepancy, here we use in silico methods to create an ideal (virtual) population of 120,000 individuals in which 50% of all cases of virtual ASD are induced by oxidative stress-associated cofactors and acetaminophen use. We demonstrate that Cox regression analysis of this ideal dataset shows little to no risk of acetaminophen use if the cofactors that create aberrant metabolism of acetaminophen are adjusted for in the analysis. Further, under-reporting of acetaminophen use is shown to be a considerable problem for this analysis, leading to large and erroneously low calculated risks of acetaminophen use. In addition, we argue that factors that impart susceptibility to acetaminophen-induced injury, and propensity for acetaminophen use itself, can be shared between the prepartum, peripartum, and postpartum periods, creating additional difficulty in the analysis of existing datasets to determine risks of acetaminophen exposure for neurodevelopment during a specific time frame. It is concluded that risks of acetaminophen use for neurodevelopment obtained from multivariate analysis of cohort data depend on underlying assumptions in the analyses, and that other evidence, both abundant and robust, demonstrate the critical role of acetaminophen in the etiology of ASD.

References
1.
Sullivan J, Farrar H . Fever and antipyretic use in children. Pediatrics. 2011; 127(3):580-7. DOI: 10.1542/peds.2010-3852. View

2.
Reid N, Moritz K, Akison L . Adverse health outcomes associated with fetal alcohol exposure: A systematic review focused on immune-related outcomes. Pediatr Allergy Immunol. 2019; 30(7):698-707. DOI: 10.1111/pai.13099. View

3.
Philippot G, Gordh T, Fredriksson A, Viberg H . Adult neurobehavioral alterations in male and female mice following developmental exposure to paracetamol (acetaminophen): characterization of a critical period. J Appl Toxicol. 2017; 37(10):1174-1181. DOI: 10.1002/jat.3473. View

4.
Decoteau C . The "Western disease": Autism and Somali parents' embodied health movements. Soc Sci Med. 2017; 177:169-176. DOI: 10.1016/j.socscimed.2017.01.064. View

5.
Dean S, Knutson J, Krebs-Kraft D, McCarthy M . Prostaglandin E2 is an endogenous modulator of cerebellar development and complex behavior during a sensitive postnatal period. Eur J Neurosci. 2012; 35(8):1218-29. PMC: 3534986. DOI: 10.1111/j.1460-9568.2012.08032.x. View